Increased research collaborations for the development of a robust drug pipeline, increased patient and physician awareness of the applications of monoclonal antibodies (mAb) therapy, and increased approval of blockbuster mAbs for a variety of applications all contribute to the market's growth. Furthermore, the use of advanced genetic engineering technology in the production of mAbs, the presence of a well-established healthcare infrastructure, government support in infection control and management, and an increase in the incidence of lifestyle-related diseases are all factors driving Monoclonal Antibodies Market growth. However, a lack of demand in developing countries is expected to limit the growth of the monoclonal antibody market. Growth opportunities in emerging markets, on the other hand, are expected to be lucrative during the forecast period.
Read More @ https://cmiinfonest.blogspot.com/2023/01/global-monoclonal-antibodies-market-is.html
